RBC Capital analyst Leonid Timashev downgraded Bicycle Therapeutics (BCYC) to Sector Perform from Outperform with a price target of $11, down from $27.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCYC: